Related references
Note: Only part of the references are listed.Screening for Prostate Cancer: Early Detection or Overdetection?
Andrew J. Vickers et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Recent updates on the role of microRNAs in prostate cancer
Oudai Hassan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Cardiac troponin I: a case study in rational antibody design for human diagnostics
P. J. Conroy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Overcoming antibody expression and screening limitations by smart design: Applications to PSA immunoassay development
C. J. Hayes et al.
PROTEIN EXPRESSION AND PURIFICATION (2012)
PSA velocity and doubling time in diagnosis and prognosis of prostate cancer
Andrew J. Vickers et al.
JOURNAL OF CLINICAL UROLOGY (2012)
Optimization of the enzyme-linked lectin assay for enhanced glycoprotein and glycoconjugate analysis
Roisin Thompson et al.
ANALYTICAL BIOCHEMISTRY (2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Carmen Jeronimo et al.
EUROPEAN UROLOGY (2011)
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
Axel Heidenreich et al.
EUROPEAN UROLOGY (2011)
Core fucosylation and α2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia
Radka Saldova et al.
GLYCOBIOLOGY (2011)
In Vitro Affinity Maturation of an Anti-PSA Antibody for Prostate Cancer Diagnostic Assay
Bruno H. Muller et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Crystal Structure of Human Prostate-Specific Antigen in a Sandwich Antibody Complex
Enrico A. Stura et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Tyramide Signal Amplification for Antibody-Overlay Lectin Microarray: A Strategy to Improve the Sensitivity of Targeted Glycan Profiling
Danni L. Meany et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Applying Random Forests To Identify Biomarker Panels in Serum 2D-DIGE Data for the Detection and Staging of Prostate Cancer
Yue Fan et al.
JOURNAL OF PROTEOME RESEARCH (2011)
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona et al.
JOURNAL OF UROLOGY (2011)
Beyond natural antibodies: the power of in vitro display technologies
Andrew R. M. Bradbury et al.
NATURE BIOTECHNOLOGY (2011)
Biomarker research in prostate cancer-towards utility, not futility
Sheng Fei Oon et al.
NATURE REVIEWS UROLOGY (2011)
Screening for Prostate Cancer
Richard M. Hoffman
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells
Ying-Chih Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Prostate Cancer: Multiparametric MR Imaging for Detection, Localization, and Staging
Caroline M. A. Hoeks et al.
RADIOLOGY (2011)
Highly sensitive recombinant antibodies capable of reliably differentiating heart-type fatty acid binding protein from noncardiac isoforms
B. Vijayalakshmi Ayyar et al.
ANALYTICAL BIOCHEMISTRY (2010)
Ultra Performance Liquid Chromatographic Profiling of Serum N-Glycans for Fast and Efficient Identification of Cancer Associated Alterations in Glycosylation
Jonathan Bones et al.
ANALYTICAL CHEMISTRY (2010)
A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness
Lori J. Sokoll et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome
Tharmala Tharmalingam et al.
CARBOHYDRATE RESEARCH (2010)
A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia
Miriam V. Dwek et al.
CLINICA CHIMICA ACTA (2010)
Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation
Penelope M. Drake et al.
CLINICAL CHEMISTRY (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Complex genetic regulation of protein glycosylation
Gordan Lauc et al.
MOLECULAR BIOSYSTEMS (2010)
A systematic approach to protein glycosylation analysis: a path through the maze
Karina Marino et al.
NATURE CHEMICAL BIOLOGY (2010)
NANOMEDICINE Barcodes check out prostate cancer
Stephen Hearty et al.
NATURE NANOTECHNOLOGY (2010)
Glycan Characterization of PSA 2-DE Subforms from Serum and Seminal Plasma
Ariadna Sarrats et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2010)
Differential Percentage of Serum Prostate-Specific Antigen Subforms Suggests a New Way to Improve Prostate Cancer Diagnosis
Ariadna Sarrats et al.
PROSTATE (2010)
Genomics Meets Glycomics-The First GWAS Study of Human N-Glycome Identifies HNF1α as a Master Regulator of Plasma Protein Fucosylation
Gordan Lauc et al.
PLOS GENETICS (2010)
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer
George Botchorishvili et al.
CURRENT OPINION IN UROLOGY (2009)
Lectins as tools in glycoconjugate research
Albert M. Wu et al.
GLYCOCONJUGATE JOURNAL (2009)
Glycoproteomics for Prostate Cancer Detection: Changes in Serum PSA Glycosylation Patterns
Danni L. Meany et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Nanoparticle-based bio-barcode assay redefines undetectable'' PSA and biochemical recurrence after radical prostatectomy
C. Shad Thaxton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds
David J. Harvey et al.
PROTEOMICS (2009)
Antibody production, design and use for biosensor-based applications
Paul J. Conroy et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software
Louise Royle et al.
ANALYTICAL BIOCHEMISTRY (2008)
GlycoBase and autoGU: tools for HPLC-based glycan analysis
Matthew P. Campbell et al.
BIOINFORMATICS (2008)
N-glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
Kazuko Matsumoto et al.
CANCER SCIENCE (2008)
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
Veronique Vitart et al.
NATURE GENETICS (2008)
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation
James N. Arnold et al.
PROTEOMICS (2008)
Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: A glycopeptide approach
Michiko Tajiri et al.
GLYCOBIOLOGY (2008)
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Hans Lilja et al.
NATURE REVIEWS CANCER (2008)
A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation
Kenta Moriwaki et al.
GLYCOBIOLOGY (2007)
Alterations in the serum glycome due to metastatic prostate cancer
Zuzana Kyselova et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Biosensor developments: application to prostate-specific antigen detection
Declan A. Healy et al.
TRENDS IN BIOTECHNOLOGY (2007)
Insignificant prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy
P. A. S. Johnstone et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial
Paul F. Pinsky et al.
UROLOGY (2006)
Genetic defects in the human glycome (vol 7, pg 537, 2006)
Hudson H. Freeze
NATURE REVIEWS GENETICS (2006)
Genetic defects in the human glycome
Hudson H. Freeze
NATURE REVIEWS GENETICS (2006)
PSA isoforms in prostate cancer detection
H Özen et al.
EUROPEAN UROLOGY SUPPLEMENTS (2006)
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
IM Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy
C Ohyama et al.
GLYCOBIOLOGY (2004)
Are multiple markers the future of prostate cancer diagnostics?
SD Mikolajczyk et al.
CLINICAL BIOCHEMISTRY (2004)
Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen
WJ Catalona et al.
JOURNAL OF UROLOGY (2004)
Prostate cancer management: (2) an update on locally advanced and metastatic disease
SRJ Bott et al.
POSTGRADUATE MEDICAL JOURNAL (2003)
Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins
R Peracaula et al.
GLYCOBIOLOGY (2003)
Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease
HJ Linton et al.
CLINICAL CHEMISTRY (2003)
Biology of prostate-specific antigen
SP Balk et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Complexed prostate specific antigen improves specificity for prostate cancer detection: Results of a prospective multicenter clinical trial
AW Partin et al.
JOURNAL OF UROLOGY (2003)
Free prostate-specific antigen in serum is becoming more complex
SD Mikolajczyk et al.
UROLOGY (2002)
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer
K Okihara et al.
JOURNAL OF UROLOGY (2002)
Biosynthesis of the carbohydrate antigenic determinants, Globo H, blood group H, and Lewis b: a role for prostate cancer cell alpha 1,2-L-fucosyltransferase
EV Chandrasekaran et al.
GLYCOBIOLOGY (2002)
Prostate specific antigen: biology, biochemistry and available commercial assays
AM Ward et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2001)
The new human tissue kallikrein gene family: Structure, function, and association to disease
GM Yousef et al.
ENDOCRINE REVIEWS (2001)
BPSA, a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia
SD Mikolajczyk et al.
UROLOGY (2000)
Share Paper
